High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Clinical trial NCT03870529 · TERMINATED

Trial details

NCT number: NCT03870529
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Stage I Lung Cancer Stage Ib Lung Carcinoma Stage IA Lung Carcinoma AJCC V7 Stage IIA Lung Carcinoma Stage IIIA Lung Carcinoma

Start date: 2019-08-19
Primary completion: 2022-12-09
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.